KINDSTAR GLOBALGENE TECHNOLOGY INCKINDSTAR GLOBALGENE TECHNOLOGY INCKINDSTAR GLOBALGENE TECHNOLOGY INC

KINDSTAR GLOBALGENE TECHNOLOGY INC

No trades
See on Supercharts

9960 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Kindstar Globalgene Technology, Inc. is an investment holding company, which engages in the provision of clinical testing services. It operates through the following segments: Hematology Testing, Genetic Diseases and Rare Diseases, Infectious Diseases, Oncology, Neurology, Maternity-Related Diseases, COVID-19 Related Testing, Routine Testing, and Others. The Others segment includes testing services for research and development projects, and others and miscellaneous services. The company was founded on August 24, 2007 and is headquartered in Wuhan, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
9960 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company